Skip to main content

Month: September 2022

Allegiance Bancshares, Inc. and CBTX, Inc. Announce Regulatory Approvals for Merger of Equals

HOUSTON, Sept. 15, 2022 (GLOBE NEWSWIRE) — Allegiance Bancshares, Inc. (NASDAQ: ABTX) (“Allegiance”), the holding company of Allegiance Bank, and CBTX, Inc. (NASDAQ: CBTX) (“CBTX”), the holding company of CommunityBank of Texas, N.A., today jointly announced receipt of regulatory approval from the Board of Governors of the Federal Reserve System to complete the previously announced merger of equals. This approval follows prior approvals from the Federal Deposit Insurance Corporation, the Texas Department of Banking and the shareholders of both companies. No further regulatory approvals are required to complete the merger of Allegiance and CBTX. Upon closing, the merger will create a premier Texas banking franchise with the scale and capabilities to provide extraordinary service to a broad range of business and consumer customers...

Continue reading

Allegiance Bancshares, Inc. and CBTX, Inc. Announce Regulatory Approvals for Merger of Equals

HOUSTON, Sept. 15, 2022 (GLOBE NEWSWIRE) — Allegiance Bancshares, Inc. (NASDAQ: ABTX) (“Allegiance”), the holding company of Allegiance Bank, and CBTX, Inc. (NASDAQ: CBTX) (“CBTX”), the holding company of CommunityBank of Texas, N.A., today jointly announced receipt of regulatory approval from the Board of Governors of the Federal Reserve System to complete the previously announced merger of equals. This approval follows prior approvals from the Federal Deposit Insurance Corporation, the Texas Department of Banking and the shareholders of both companies. No further regulatory approvals are required to complete the merger of Allegiance and CBTX. Upon closing, the merger will create a premier Texas banking franchise with the scale and capabilities to provide extraordinary service to a broad range of business and consumer customers...

Continue reading

Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advancements in Producing PHA Bioplastic in Camelina at the ISBP 2022 Conference

WOBURN, Mass., Sept. 15, 2022 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that its Chief Science Officer Dr. Kristi Snell will present during the International Symposium on Biopolymers (“ISBP”) 2022 Conference. The event is taking place September 12 through September 16, 2022 in Sion, Switzerland. Dr. Snell will make a presentation on Friday, September 16, during the session entitled “Industrial Feedstocks and Polymer Production” scheduled for 9:20 am to 11:00 am local time (3:20 am to 5:00 am ET). Her presentation entitled “Breakthroughs in Plant Based Polyhydroxybutyrate (PHB) Production” will describe the successful engineering of a bacterial pathway for producing PHB in the cytosol of Camelina seed. Yield10 researchers are conducting...

Continue reading

Devon Energy Announces Executive Chairman Retirement and Succession Plan

OKLAHOMA CITY, Sept. 15, 2022 (GLOBE NEWSWIRE) — Devon Energy Corp. (NYSE: DVN) announced today that the company’s board of directors expects to appoint Barbara Baumann as chair of the board, succeeding Dave Hager, who has notified the board of his plans to retire from the board in January 2023. This transition aligns with Devon’s continuing focus on strong corporate values, governance principles, and strategic vision. “It has been a great joy and a privilege to spend the past 15 years with this great company and I am very proud of what our high-quality team has accomplished during this time to position Devon for the success it is having today,” said Dave Hager, executive chairman. “I have high confidence in the strategic direction of Devon, and I know that the company is in good hands with Rick and Barbara’s leadership to...

Continue reading

Mercury Systems announces appointment of Allen Couture as senior vice president of execution excellence

Allen Couture Allen Couture, Mercury SVP of Execution ExcellenceANDOVER, Mass., Sept. 15, 2022 (GLOBE NEWSWIRE) — Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com), a leader in trusted, secure mission-critical technologies for aerospace and defense, today announced that Allen Couture will join the company as Senior Vice President of Execution Excellence, effective October 3, 2022. In this customer-centric role reporting to Mercury CEO Mark Aslett, Mr. Couture will have a matrixed responsibility for engineering, supply chain, operations, quality, and program management to ensure Mercury has systems, processes, and talent that can scale to support Mercury’s growth strategy. Mr. Couture has spent the last 10 years in leadership roles with Raytheon Technologies, most recently serving as Vice President of Operations & Security...

Continue reading

EnerSys Announces Date and Webcast Information for Its Tech Talk Focused on Thin Plate Pure Lead (TPPL) Technology

READING, Pa., Sept. 15, 2022 (GLOBE NEWSWIRE) — EnerSys (NYSE: ENS), the global leader in stored energy solutions for industrial applications, announced today Joern Tinnemeyer, Senior Vice President and Chief Technology Officer, and Shawn O’Connell, President Motive Power Global, will host a Tech Talk focused on the strategic advantages of the company’s TPPL technology and diverse set of energy solutions in the motive power industry. The virtual event will be hosted on Tuesday, September 27, 2022, at 3:00 p.m. ET. A live broadcast as well as a replay of the event can be accessed through the Events and Presentation page of the Investor Relations section of the company’s website at https://investor.enersys.com/events-presentations. Dial-in information will be available in the event details closer to the call. Additional ResourcesThin...

Continue reading

Compass Diversified-Backed 5.11 Tactical® Announces the Opening of its 100th Retail Store Location

IRVINE, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) — 5.11 Tactical® (“5.11”), a subsidiary of Compass Diversified (NYSE: CODI) (“CODI” or the “Company”) and the global innovator of purpose-built apparel, footwear and gear, today announced the grand opening of its 100th retail store in Oxnard, California, on Saturday, September 17, 2022. “I’m proud of the 5.11 team’s relentless commitment to our retail strategy, which bring us to the opening of our 100th retail store this weekend,” said Francisco J. Morales, CEO of 5.11. “This is an incredible milestone to celebrate at 5.11, as our increased retail presence allows existing customers to continue to experience our products while offering more opportunities to engage customers at new locations. Since partnering with CODI in 2016, we have made significant investments that have enabled...

Continue reading

Syros and Tyme Technologies Announce Stockholder Approval of Merger

— Combined Company to Trade on Nasdaq Under Ticker “SYRS” —— Syros Announces 1-for-10 Reverse Stock Split of Common Stock — CAMBRIDGE, Mass. and BEDMINSTER, N.J., Sept. 15, 2022 (GLOBE NEWSWIRE) — Syros Pharmaceuticals, Inc. (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, and Tyme Technologies, Inc. (NASDAQ:TYME) today announced the results of the special meetings of the stockholders of Syros and TYME, respectively, each held on September 15, 2022. At TYME’s special meeting, TYME’s stockholders voted in favor of all proposals, including the proposal to adopt the agreement and plan of merger, dated July 3, 2022 (the “Merger Agreement”), pursuant to which a direct, wholly owned subsidiary of Syros will merge with and into TYME, with TYME surviving as a wholly owned...

Continue reading

Rezolute Reports Fourth Quarter and Full Year Fiscal 2022 Results and Highlights Company Progress

Announced a $130 million registered direct offering and concurrent private placement priced at-the-market Late-breaking oral presentation from Phase 2b RIZE study of RZ358 presented at ESPE 2022 Phase 2 proof-of-concept study of RZ402 expected to be initiated later this year REDWOOD CITY, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company dedicated to developing transformative therapies with the potential to shift the treatment paradigms of devastating metabolic diseases, today announced its financial results for the fourth quarter and full fiscal year ended June 30, 2022. “This quarter marked steady progress as we continue to drive our clinical programs forward, including RZ358 for congenital hyperinsulinism and RZ402 for diabetic macular edema,” said Nevan Charles...

Continue reading

PRESS RELEASE: NACON: ISSUANCE OF NEW SHARES IN CONNECTION WITH THE ACQUISITION OF BIG ANT STUDIOS

                                                Press release Lesquin, 15 September 2022 18:00hrs ISSUANCE OF NEW SHARES IN CONNECTION WITH THE ACQUISITION OF BIG ANT STUDIOS   On January 21, 2021, the Company announced the acquisition of Big Ant Studios, a leading Australian video game studio in major sports such as rugby, tennis and cricket. As specified in the terms of the transaction, the acquisition agreement provided for the payment of earnouts based on performance criteria to the selling partners. Given the strong performance of Big Ant Studios, some of the performance criteria previously established have been met. The selling partners of Big Ant Studios have decided to reinvest half of their earn-outs in the capital of the Company. Thus, the Board of Directors of the Company has decided today, using the delegation of authority...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.